Getty Images; Alyssa Powell/BI
The copycat weight-loss drugs party was supposed to be over, but it's still raging on.
Because of shortages of the name-brand medications — Ozempic or Wegovy for semaglutide and Zepbound or Mounjaro for tirzepatide — the FDA allowed a flood of providers to jump into the market over the past few years with cheaper, off-brand versions called compounded drugs. The FDA




